Gabapentin is a nonprotein amino acid and a synthetic neurotransmitter that is related to γ-aminobutyric acid1 (GABA). It was first described in 1976 West German patent DE2460891 on cyclic amino acids to Gerhard Satzinger and co-inventors at Goedecke AG (Freiburg). The corresponding US Patent is 4,024,175 (1977). Gabapentin and Lyrica, both sold by Pfizer, have been approved by the Food and Drug Administration to treat only four debilitating pain problems: postherpetic neuralgia, diabetic neuropathy Gabapentin, commonly sold under the brand name Neurontin, is a prescription drug used to treat seizures, restless leg syndrome, and pain caused by shingles. While it has been effective for some patients, there have been several cases of adverse effects and potential health concerns associated with its use. In recent years, the manufacturers of Gabapentin have faced legal challenges as a result Gabapentin, sold under the brand name Neurontin among others, is an anticonvulsant medication used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome. [2][3] It is recommended as one of a number of first-line medications for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. [8] About 15% of Gabapentin is an anticonvulsive medication that received approval from the US Food and Drug Administration (FDA) in 1993 and has been available in generic form in the USA since 2004. Gabapentin was originally used as a muscle relaxant and an anti-spasmodic. However, it was later discovered that gabapentin has the potential of an anticonvulsive medication and can be used as an adjunct to more The entry of generic versions of gabapentin into the market has intensified competition and driven down prices, impacting the revenue streams of key pharmaceutical companies. To counter this, manufacturers are developing combination products that contain gabapentin and other medications to improve efficacy or reduce adverse effects. The ‘482 patent states that under certain conditions, gabapentin has a tendency to form a lactam, which makes the drug unstable, and is linked to causing seizures rather than preventing them. Q: How do pharmaceutical industry payments influence gabapentin prescriptions? A: Payments from gabapentin manufacturers to physicians have been linked to a higher likelihood of prescribing brand-name versions of gabapentin, which are more expensive than generic versions [5]. Q: What challenges does the gabapentin market face? This product information is intended only for residents of the United States. In order to properly inform the public, we have developed the following statement to be placed at the top of certain product pages: The products on this page have been transferred to VIATRIS SPECIALTY LLC. The U.S. Physician Prescribing Information and Patient Information on this page may no longer be current. Please Gabapentin, sold under the brand name Neurontin among others, is an anticonvulsant medication primarily used to treat neuropathic pain and also for partial seizures [10][7] of epilepsy. It is a commonly used medication for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central pain. [11] It is moderately effective: about 30–40% of those given Gabapentin Patents Given below is the list of patents protecting Gabapentin, along with the drug name that holds that patent and the company name owning that drug. Gabapentin is a medication commonly prescribed for the treatment of various conditions, including epilepsy, neuropathic pain, and restless legs syndrome. Different pharmaceutical companies may manufacture and distribute gabapentin under various brand names. Welcome to our website for NorthStaRx® and Aisling® – leading global suppliers of high-quality, affordable generic pharmaceuticals with expertise in meeting the wide-ranging, ever-growing needs of healthcare customers worldwide. Gabapentin, approved for seizures and postherpetic neuralgia, has become widely used off-label for ailments like fibromyalgia, neuropathy, and insomnia. Although helpful for some, its side effects Rising Pharma Holdings, Inc., d/b/a Rising Pharmaceuticals is an emerging industry leader in the marketing and distribution of prescription generics, committed to delivering high-quality, accessible medications in the United States. From our manufacturers, partners, and pharmacies to physicians and their patients, our goal is to make life better for everyone we serve. Our versatile portfolio Pfizer, the world's largest drug maker, pleaded guilty on 13 May to numerous civil and criminal charges for illegally promoting the off-label use of gabapentin (Neurontin). It has agreed to pay a $240m (£136m; €200m) criminal fine and $152m to state and federal healthcare programmes. The fine is the second largest given in the industry. Meanwhile, off-label sales of gabapentin continue to XLCare Pharmaceuticals is located in Central Islip, New York. Our Generic Pharmaceutical operates in the Pharmaceuticals business / industry within the Government market – Goods sector. We have been operating for over 3 years now with great success. As an organization, our past, our mission and our principles tell us who we are. Louise Crane Gabapentin has been described as a ‘wonder drug’ for its ability to treat neuropathic pain, restless leg syndrome, migraine, bipolar disorder, drug and alcohol dependence, attention deficit disorder, premenstrual syndrome, and much more. It is a pharmacologically active amino acid, created as a potential epilepsy drug in 1974 by the pharmaceutical company Parke-Davis, now Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the Off-label marketing strikes again. Pfizer agreed to pay $325 million to wrap up claims that its Parke-Davis unit touted the epilepsy drug Neurontin for uses not approved by the FDA, costing
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |